Silverfin false false 30/11/2025 30/11/2025 01/12/2024 The principal activity of the Company during the financial year was of management consultancy and manufacturing of pharmaceutical preparations. I M T Sodevall-Takenoshita 06/04/2023 T Takenoshita 27/07/2018 11488309 2025-11-30 11488309 bus:Director1 2025-11-30 11488309 bus:Director2 2025-11-30 11488309 2024-11-30 11488309 core:CurrentFinancialInstruments 2025-11-30 11488309 core:CurrentFinancialInstruments 2024-11-30 11488309 2024-12-01 2025-11-30 11488309 bus:Micro-entities 2024-12-01 2025-11-30 11488309 bus:FilletedAccounts 2024-12-01 2025-11-30 11488309 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 11488309 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 11488309 bus:Director1 2024-12-01 2025-11-30 11488309 bus:Director2 2024-12-01 2025-11-30 11488309 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Company No: 11488309 (England and Wales)

# LIVBIO LIMITED

### Unaudited Financial Statements
For the financial year ended 30 November 2025
Pages for filing with the registrar

LIVBIO LIMITED

## UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 30 November 2025

Contents

LIVBIO LIMITED

## STATEMENT OF FINANCIAL POSITION

As at 30 November 2025
LIVBIO LIMITED

## STATEMENT OF FINANCIAL POSITION (continued)

For the financial year ended 30 November 2025

|  | 2025 |  | 2024
|  | £ |  | £
Fixed assets |  | 3,062 |  | 1,919
Current assets |  | 432,190 |  | 482,483
Prepayments and accrued income |  | 10,173 |  | 1,943
Creditors: amounts falling due within one year |  | ( 55,098) |  | ( 44,036)
Net current assets |  | 387,265 |  | 440,390
Total assets less current liabilities |  | 390,327 |  | 442,309
Accruals and deferred income |  | ( 4,603) |  | ( 4,294)
Net assets |  | 385,724 |  | 438,015
Capital and reserves |  | 385,724 |  | 438,015

For the financial year ending 30 November 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Livbio Limited (registered number: 11488309) were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

T Takenoshita Director |

11 August 2026

LIVBIO LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2025
LIVBIO LIMITED

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 30 November 2025

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 11488309). The address of its registered office is 128 City Road, London, EC1V 2NX, United Kingdom.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the financial year, including directors | 2 |  | 2